New Drugs of 2021 – Nurse, Nurse Practitioner

  Price  $6.95

  Credits  1.5

Clear


Format

In 2021, the U.S. Food and Drug Administration (FDA) approved 50 novel drugs along with approvals for the use of approved drugs for new indications and patient populations. Twenty-seven of the 50 novel drugs approved in 2021 were the first in their class. These first-in-class drugs bring new treatments to conditions like Alzheimer’s Disease, vulvovaginal candidiasis, eczema, chronic kidney disease, and several autoimmune diseases. This issue of The Rx Consultant focuses on new drugs approved in 2021 that may be important additions to the treatment of conditions commonly seen by community practitioners.

$6.95

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Nurse

Nurse Practitioner

Author

Golden L. Peters
PharmD, BCPS
Erin K. Hennessey
PharmD, BCPS
Erin Raney
PharmD, BCPS, BC-ADM, FCCP
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Nurse

Nurse

  • Identify brand/generic names, FDA-approved indication(s), recommended dose(s), interactions, adverse reactions, precautions, and contraindications for newly approved drugs reviewed in detail.
  • Recall the efficacy and safety outcomes of studies for newly approved drugs reviewed in detail.
  • Identify patient counseling points for newly approved drugs reviewed in detail.
  • Recognize brand/generic names, indications, and mechanism of action of newly approved drugs briefly summarized in Table 2.

Nurse Practitioner

Nurse Practitioner

  • Identify brand/generic names, FDA-approved indication(s), recommended dose(s), interactions, adverse reactions, precautions, and contraindications for newly approved drugs reviewed in detail.
  • Recall the efficacy and safety outcomes of studies for newly approved drugs reviewed in detail.
  • Identify patient counseling points for newly approved drugs reviewed in detail.
  • Recognize brand/generic names, indications, and mechanism of action of newly approved drugs briefly summarized in Table 2.

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    894739
  • Universal Activity Number:
    Nurse : 0798-0000-22-046-H01
    Nurse Practitioner : 0798-0000-22-046-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

Credit for this program is issued by passing the final test hosted at www.RxConsultant.com with a score of 70% or higher.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.